Tue, May 6, 1:31 PM (16 days ago)
**Novanta Inc. (NOVT) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Revenue:** $233.4 million, up 1.1% YoY. - **Gross Profit:** $104.4 million, up 4% YoY. - **Operating Income:** $32.4 million, up 26.6% YoY. - **Net Income:** $21.2 million, up 44.6% YoY. - **Earnings per Share (EPS):** $0.59, up 43.9% YoY. **Profit Margins:** - **Gross Margin:** 44.7%, up from 43.5% YoY. - **Operating Margin:** 13.9%, up from 11.1% YoY. - **Net Margin:** 9.1%, up from 6.3% YoY. **Cash Flow:** - **Operating Cash Flow:** $31.7 million, down from $32.8 million YoY. - **Investing Cash Flow:** $1.3 million, up from -$197.6 million YoY. - **Financing Cash Flow:** -$42.7 million, down from $153.5 million YoY. **Segment Performance:** - **Automation Enabling Technologies:** Revenue up 4.9% YoY, Operating Income up 32.1% YoY. - **Medical Solutions:** Revenue down 2.9% YoY, Operating Income down 12.4% YoY. **Trends & Uncertainties:** - **Revenue Growth:** Driven by increased demand in robotics and automation products. - **Margin Expansion:** Due to improved product mix and operational efficiencies. - **Acquisitions:** Keonn Technologies acquired for $66.4 million, with potential contingent consideration of $21.9 million. - **Economic Uncertainties:** Global economic conditions, geopolitical tensions, and inflationary pressures may impact future performance. **Future Operations Impact:** - **Growth Strategy:** Focus on medical and advanced industrial markets, new product introductions, and strategic acquisitions. - **Cost Management:** Ongoing restructuring programs to reduce operating complexity and improve efficiency. - **Liquidity:** Strong cash position and available credit facilities to support future growth and acquisitions. **Ticker:** NOVT